Novatr vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
AEC professional upskilling platform teaching BIM, Revit, and computational design to architects and engineers; ₹46 Crore ($6M) revenue in 2024 backed by YC serving 5,000+ learners in 35+ countries.
About
Novatr is a Gurugram-based edtech company providing professional upskilling courses for architects, engineers, and designers in Building Information Modeling (BIM), computational design, and Revit — the software skills that are increasingly required in modern construction projects but not taught adequately in architecture and engineering school curricula. Founded in 2019 and a Y Combinator graduate backed by Powerhouse Ventures and Soma Capital with $1.32 million raised, Novatr served 5,000+ learners across 35+ countries, achieved ₹46 crore ($6 million) in revenue in 2024, and delivers 6-month intensive cohort programs with industry-recognized certifications.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.